The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of FDG PET-CT (PET) avid skeletal lesions (SL) with progression-free survival (PFS) in patients (pts) with previously untreated follicular lymphoma (FL).
 
Joseph J. Maly
No Relationships to Disclose
 
Lai Wei
No Relationships to Disclose
 
Jessica Hemminger
No Relationships to Disclose
 
Beth Christian
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Genentech/Roche; Immunomedics; Janssen; Merck; Pharmacyclics; Seagen
 
Kami J. Maddocks
Honoraria - Bristol-Myers Squibb; Janssen; Pharmacyclics; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Pharmacyclics; Seagen
Research Funding - Merck; Pharmacyclics
 
Jeffrey Alan Jones
Consulting or Advisory Role - Abbvie; Acerta Pharma; Alexion Pharmaceuticals; Gilead Sciences; Janssen Oncology; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst)
 
Chad Wright
No Relationships to Disclose
 
Kristie A. Blum
Research Funding - Constellation Pharmaceuticals (Inst); Janssen (Inst); Millennium (Inst); MorphoSys (Inst); Novartis (Inst); Pharmacyclics (Inst)